Alternatives to Regis Technologies

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biotechnology company developing novel immunotherapies for cancer.